Quick Heal Technologies (QUICKHEAL) Q1 25/26 earnings summary

Executive summary

• Q1 FY26 net revenue was ₹57.23 crore, down 18.6% year-over-year, with declines in both consumer and enterprise segments.

• EBITDA loss stood at ₹9.7 crore, with profit after tax at -₹5.5 crore.

• International revenue doubled year-over-year, driven by strategic account wins and new product launches.

• Management transition underway, with CEO resignation and new appointments; legal and leadership transitions ongoing.

• Innovation included launches of AntiFraud.AI Premium, Anti Fraud Freemium, and AI-driven threat detection platforms.

Financial highlights

• Revenue from operations was ₹57.23 crore in Q1 FY26, down from ₹70.29 crore year-over-year and ₹65.14 crore in the previous quarter.

• Gross margin improved to 98.5% in Q1 FY26 from 97.7% in Q1 FY25.

• Operating expenditure remained steady at ₹66 crore year-over-year; total expenses for the quarter were ₹69.98 crore.

• EBITDA margin declined to -17.0% in Q1 FY26; PAT margin dropped to -9.6%.

• Basic and diluted EPS for the consolidated quarter were both negative at ₹(1.00).

Outlook and guidance

• Focus on revenue recovery, expense management, and expanding into higher customer segments and select international geographies.

• Continued investment in new product launches, cloud-native applications, and AI adoption.

• No explicit quantitative guidance provided; order book and pipeline expected to support future growth.

• Management notes ongoing legal and leadership transitions.